Skip to main navigation
Skip to content
Top Bar
  • Careers
  • Contact Us
Cyclacel Pharmaceuticals, Inc.
Header Nav - Desktop
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
Cyclacel Pharmaceuticals, Inc.

Investors

Event Details

Sign up for email alerts to receive company and investor updates
Investor Relations
  • Investor Relations
  • News Releases
  • Presentations & Events
  • Common Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Corporate Governance
    • Overview
    • Board of Directors
    • Committee Composition
    • Management Team
  • Annual Reports

Second Quarter 2022 Financial Results

Aug 10 2022 at 4:30 PM EDT

Listen to Webcast
Toolkit
Email AlertsRSS FeedsPrint Page
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Cyclacel Pharmaceuticals, Inc. logo

200 Connell Drive #1500
Berkeley Heights, NJ 07922
United States of America

  • E: info@cyclacel.com
  • T: +1 (908) 517 7330

Sign up for email alerts ยป

Footer Social
  • Twitter
  • LinkedIn
Footer Links
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap

© 2024 Cyclacel Pharmaceuticals, Inc.